Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Nepean Cancer Care Centre, Kingswood, NSW, Australia.
J Telemed Telecare. 2024 Feb;30(2):320-326. doi: 10.1177/1357633X211045586. Epub 2021 Oct 16.
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a widespread adoption of telehealth (phone and video consultations) in cancer care worldwide. The aim of this study was to determine patient satisfaction with telehealth consultations with their medical oncologist at a tertiary cancer centre in Sydney, Australia.
Patients who attended a routine telehealth appointment at the medical oncology outpatient clinic were recruited to complete a questionnaire containing 16 items, each on a 5-point Likert scale regarding satisfaction levels in various aspects of telehealth and their willingness to continue telehealth after the pandemic. Patients were also invited to provide suggestions for improvement.
In total, 150 patients were invited to participate, and 103 valid questionnaires were returned. Median age was 63 years (range: 25-90), 49% of patients were male, 63% of patients had advanced cancer and 81% were on active treatment. In total, 95% of participants indicated that they were satisfied (score ≥4) with telehealth. 82% of participants preferred to continue telehealth consultations after the coronavirus disease 2019 pandemic, but ideally with a mix of telehealth and in-person consultations. Phone appointments (vs. video, < 0.002), patients with advanced cancer (vs. early, < 0.036) and pre-chemotherapy/immunotherapy/targeted therapy treatment reviews (vs. follow-up appointments, < 0.001) were significantly associated with a willingness to continue telehealth.
Patients were overwhelmingly satisfied with telehealth during the study period and were willing to continue telehealth for some appointments beyond the coronavirus disease 2019 pandemic. More research into the effectiveness, safety and implementation of telehealth to compliment traditional face-to-face services for patient-centred cancer care is required.
2019 年冠状病毒病(COVID-19)大流行导致全球癌症护理中广泛采用远程医疗(电话和视频咨询)。本研究旨在确定澳大利亚悉尼一家三级癌症中心的患者对与他们的肿瘤内科医生进行远程医疗咨询的满意度。
在肿瘤内科门诊进行常规远程医疗预约的患者被招募来完成一份包含 16 个项目的问卷,每个项目的满意度均为 5 分制,涉及远程医疗各个方面的满意度以及他们在 COVID-19 大流行后继续远程医疗的意愿。患者还被邀请提供改进建议。
共邀请了 150 名患者参加,有 103 份有效问卷。中位年龄为 63 岁(范围:25-90),49%的患者为男性,63%的患者为晚期癌症,81%的患者正在接受积极治疗。共有 95%的参与者表示对远程医疗感到满意(得分≥4)。82%的参与者表示愿意在 COVID-19 大流行后继续进行远程医疗咨询,但理想情况下是远程医疗和面对面咨询相结合。与视频咨询相比,电话预约( < 0.002)、晚期癌症患者( < 0.036)和化疗/免疫治疗/靶向治疗前治疗评估( < 0.001)与继续进行远程医疗的意愿显著相关。
在研究期间,患者对远程医疗非常满意,并且愿意在 COVID-19 大流行后继续进行某些预约的远程医疗。需要进一步研究远程医疗的有效性、安全性和实施情况,以补充传统的面对面服务,为以患者为中心的癌症护理提供支持。